KRT6A Derived From Mesenchymal Stem Cells as a Potential Biomarker and Therapeutic Target for Alopecia Areata: Insights From Multi-Omics Analysis and Experimental Evidence
May 2026
in “
Stem Cell Research & Therapy
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
Studysummary In this study, researchers identified KRT6A as a potentially important gene in mesenchymal stem cell-derived treatments for alopecia areata, revealing its role as a diagnostic marker, predictor of disease severity, and a protective factor, with overexpression alleviating hair loss in experimental models.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer